Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03444922 · ClinicalTrials.gov registry record · NA
Effects of BPA on Insulin and Glucose Responses
A NA study of Environmental Exposure, sponsored by California Polytechnic State University-San Luis Obispo.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT03444922: Completed NA study of Environmental Exposure, sponsored by California Polytechnic State University-San Luis Obispo.
NCT03444922 is a NA study of Environmental Exposure that has completed, run by California Polytechnic State University-San Luis Obispo. The registered enrollment target is 11 participants, below the 289-participant average among 13 other Environmental Exposure trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03444922, a NA study of Environmental Exposure, has completed, sponsored by California Polytechnic State University-San Luis Obispo.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
The National Institutes of Health has encouraged research examining effects of BPA, yet evidence in humans evaluating the effects of BPA on insulin and glucose concentrations remains exclusively associative in nature. Thus, the primary purpose of this study is to determine whether an acute oral ingestion of BPA impacts insulin and glucose concentrations, and other endocrine factors (Pro-insulin, C-Peptide, Estrogen, triglycerides). Findings from this pilot study will inform public health recommendations for food packaging and provide much needed experimental evidence as to whether BPA poses any public health risk.
Primary Outcome
Glucose concentrations will be assessed before and in response to a 75 gram Oral Glucose Tolerance Test
Conditions Studied
Interventions
- OTHER Placebo
- OTHER BPA 4 ug/kg BW
- OTHER BPA 50 ug/kg BW
Study Locations (1)
California
- California Polytechnic State University - San Luis Obispo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2016-09-01 |
| Est. Completion | 2019-02-14 |
| Phase | NA |
What the finished NCT03444922 record still lists
NCT03444922 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 289-participant average among 13 other Environmental Exposure trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Environmental Exposure appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT03444922 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03444922 about?
NCT03444922 is a clinical study titled "Effects of BPA on Insulin and Glucose Responses". The National Institutes of Health has encouraged research examining effects of BPA, yet evidence in humans evaluating the effects of BPA on insulin and glucose concentrations remains exclusively associative in nature. Thus, the primary purpose of this study is to determine whether an acute oral inge...
What is the current status of trial NCT03444922?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2016-09-01. Estimated completion is 2019-02-14.
What conditions does trial NCT03444922 study?
This clinical trial studies the following conditions: Environmental Exposure.
What interventions are being tested in trial NCT03444922?
The interventions under investigation include: Placebo (OTHER), BPA 4 ug/kg BW (OTHER), BPA 50 ug/kg BW (OTHER).
Who is sponsoring clinical trial NCT03444922?
This trial is sponsored by California Polytechnic State University-San Luis Obispo, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03444922 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Environmental Exposure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03444922's enrollment target sits among peer trials
11 12th of 13 higher than 2 of 13 other Environmental Exposure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Environmental Exposure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessing and Addressing Community Exposures to Environmental Contaminants
RECRUITING · NA
-
Childhood Activities Nutrition and Development Oversight
RECRUITING · NA
-
Table-Top Water Pitcher to Reduce Arsenic Exposure Among Well Users in New Hampshire
RECRUITING · NA
-
A Personalized Biomonitoring and Report-back Intervention to Reduce Exposure to Endocrine Disrupting Chemicals
ACTIVE NOT RECRUITING · NA
-
The IGNITE Study on Concentrated Investment in Black Neighborhoods
ACTIVE NOT RECRUITING · NA
-
Sleep Improvement Via Environmental Smart Temperature Adjustments
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI